Biomaterial Database

Serial studies of auditory neurotoxicity in patients receiving deferoxamine therapy. 1989

C Schindléry, and V Macarol

UI	MeSH Term	Description	Entries
D003676	Deferoxamine	Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.	Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005293	Ferritins	Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.	Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001304	Auditory Diseases, Central	Disorders of hearing or auditory perception due to pathological processes of the AUDITORY PATHWAYS in the CENTRAL NERVOUS SYSTEM. These include CENTRAL HEARING LOSS and AUDITORY PERCEPTUAL DISORDERS.	Auditory Cortex Disorder,Central Auditory Diseases,Auditory Dysfunction, Central,Auditory Pathway Disorders, Central,Central Auditory Pathway Disorders,Auditory Cortex Disorders,Auditory Disease, Central,Central Auditory Disease,Central Auditory Dysfunction,Cortex Disorder, Auditory,Cortex Disorders, Auditory,Dysfunction, Central Auditory,Dysfunctions, Central Auditory